18-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Canceranglais
Version: 2 ID: 7-20 Version 2 oct 2012
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Adult patients with lung cancer.
What is the role of 18-Fluorodeoxyglucose (18FDG) Positron Emission Tomography (PET) in:
- The diagnosis of solitary pulmonary nodules (SPN)?
- The staging of primary non-small cell lung cancer (NSCLC) at initial diagnosis?
- The staging of primary small cell lung cancer (SCLC)? Outcomes of interest include accuracy measures of imaging and the impact of PET on patient management and patient outcomes.
Summary (PDF) (77.83 Ko)
Full Report (PDF) (342.58 Ko)